Related Experiment Videos
Association of juvenile disciform maculopathy with HLA B15
Abstract:
Twenty patients with juvenile disciform maculopathy (JDM), which clinically cannot be differentiated from presumed ocular histoplasmosis, are presented. Histocompatibility antigen typing showed an increase in HLA B15, but this increase was not significant with respect to the corrected P-value. We are reporting our results in the hope of encouraging those who have cases of JDM in Europe to consider histocompatibility antigens and in particular HLA B15.
Insights
Juvenile disciform maculopathy (JDM) shares clinical similarities with presumed ocular histoplasmosis. HLA B15 antigen levels were elevated in JDM patients, though not significantly. Further research into HLA B15 in European JDM cases is encouraged.
Area of Science:
- Ophthalmology
- Immunogenetics
Background:
- Juvenile disciform maculopathy (JDM) presents clinically similar to presumed ocular histoplasmosis.
- Differentiating these conditions is crucial for appropriate management.
Purpose of the Study:
- To investigate potential genetic associations in patients with JDM.
- To explore the role of histocompatibility antigens, specifically HLA B15, in JDM.
Main Methods:
- Histocompatibility antigen typing was performed on twenty JDM patients.
- Analysis focused on the prevalence of specific HLA antigens, including HLA B15.
Main Results:
- An increased prevalence of the HLA B15 antigen was observed in the JDM patient cohort.
- This observed increase did not reach statistical significance after correcting for multiple comparisons.
Conclusions:
- The study suggests a potential, though not statistically significant, association between HLA B15 and JDM.
- Researchers encourage European clinicians managing JDM cases to consider HLA antigen typing, particularly for HLA B15.